報價延遲最少15分鐘:2026/04/04 00:53 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
63.57 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
8.88/6.65
|
|
企業價值
16.20B
|
| 資產負債 |
|
每股賬面淨值
29.12
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
8.33B
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally. |
